Research Advances in Benign Hematology
Each year, numerous BIDMC research faculty are:
Published in prestigious scientific and medical journals
Awarded prominent and highly competitive research grants
Recognized for far-ranging scientific achievement
Engaged in clinical trials, to bring research from the laboratory bench
to the patient bedside
You may benefit from standard treatment protocols that improve the outcome
of your particular blood disorder. Or you may qualify for one of our
clinical trials - research studies that are designed to find better
treatments for patients based on the most updated information from around
As a founding member of the Dana Farber/Harvard Cancer Center (DF/HCC),
Beth Israel Deaconess has access to a broad array of the most current
clinical trials, including those that pertain to benign blood disorders.
Ask your hematologist if you qualify for one of the blood-disorder trials
we offer through the DF/HCC.
- APIXABAN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER: A PROSPECTIVE RANDOMIZED OPEN BLINDED END-POINT (PROBE) STUDY - THE CARA-VAGGIO STUDY - Learn More.
- A Double-Blind, Double-Dummy Phase 2 Randomized Study to Evaluate the Efficacy and Safety of Ruxolitinib Versus Anagrelide in Subjects with Essential Thrombocythemia Who Are Resistant to or In-tolerant of Hydroxyurea - Learn More.
- Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) - Learn More.
- A randomized, phase II study of weight-based versus standard dose enoxaparin thromboprophylaxis in high-risk hospitalized cancer patients. - Learn More.
Updated November 2018.
Key Research Areas
BIDMC's research strengths pertaining to benign hematology are chiefly:
Coagulation and platelet disorders
Vascular biology, which interfaces with research pertaining to solid
Cellular and molecular biology of hematopoiesis (how blood cells
New treatment and prevention strategies for chronic anemia
The role of red blood cells in infectious disease and in the immune
The role eosinophils, white blood cells, may play in allergies and